88 related articles for article (PubMed ID: 415623)
21. [Cervix cancer screening: results of a french team].
Salvat J; Slamani L; Schmidt MH
Rev Med Suisse Romande; 1997 Aug; 117(8):593-6. PubMed ID: 9340713
[No Abstract] [Full Text] [Related]
22. [Costs and problems in cervix cancer screening are considerably underestimated].
Bistoletti P
Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
[No Abstract] [Full Text] [Related]
23. The epidemiological basis for cervical cancer screening.
Bailie R
S Afr Med J; 1995 Jan; 85(1):8-10. PubMed ID: 7784937
[No Abstract] [Full Text] [Related]
24. Screening for cervical cancer.
Clarke EA
CMAJ; 1998 Feb; 158(3):301-2. PubMed ID: 9484250
[No Abstract] [Full Text] [Related]
25. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
26. An economic appraisal of a mobile cervical cytology screening service.
Bloch B
S Afr Med J; 1997 Feb; 87(2):231. PubMed ID: 9180819
[No Abstract] [Full Text] [Related]
27. National cervical cancer prevention program in the Arab States: Strategies and cost-minimization study of the Tunisian case.
Gamaoun R
Vaccine; 2018 Aug; 36(33):5091-5096. PubMed ID: 29983258
[TBL] [Abstract][Full Text] [Related]
28. Cervical screening: what is the point?
Sasieni P
Lancet; 1995 Jul; 346(8969):244; author reply 246-7. PubMed ID: 7616810
[No Abstract] [Full Text] [Related]
29. Liquid-based cytology in cervical screening: a rapid and systematic review.
Payne N; Chilcott J; McGoogan E
Health Technol Assess; 2000; 4(18):1-73. PubMed ID: 10932023
[No Abstract] [Full Text] [Related]
30. [Screening for cancer of the cervix].
Schaffer P
Bull Cancer; 1996 Sep; 83(9):736-41. PubMed ID: 8952649
[No Abstract] [Full Text] [Related]
31. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
Guerrero AM; Genuino AJ; Santillan M; Praditsitthikorn N; Chantarastapornchit V; Teerawattananon Y; Alejandria M; Toral JA
BMC Public Health; 2015 Jul; 15():730. PubMed ID: 26223975
[TBL] [Abstract][Full Text] [Related]
32. [Cervical cancer screening. A gynecologist's point of view. Role of colposcopy].
Dargent D
Bull Cancer; 1996 Sep; 83(9):742-5. PubMed ID: 8952650
[No Abstract] [Full Text] [Related]
33. Screening for cervical cancer in the era of the HPV vaccine--the urgent need for both new screening guidelines and new biomarkers.
Kiviat NB; Hawes SE; Feng Q
J Natl Cancer Inst; 2008 Mar; 100(5):290-1. PubMed ID: 18314471
[No Abstract] [Full Text] [Related]
34. [Cost-benefit analysis of the Program for Early Screening of Cervico-uterine Cancer].
Hernández-Peña P; Lazcano-Ponce EC; Alonso-de Ruiz P; Cruz-Valdez A; Meneses-González F; Hernández-Avila M
Salud Publica Mex; 1997; 39(4):379-87. PubMed ID: 9381251
[TBL] [Abstract][Full Text] [Related]
35. Improving the sensitivity of cervical cytology: what are the issues?
Myers ER
Am J Manag Care; 2000 Jul; 6(7):838-40. PubMed ID: 11067380
[No Abstract] [Full Text] [Related]
36. Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China.
Levin CE; Sellors J; Shi JF; Ma L; Qiao YL; Ortendahl J; O'Shea MK; Goldie SJ
Int J Cancer; 2010 Sep; 127(6):1404-11. PubMed ID: 20049838
[TBL] [Abstract][Full Text] [Related]
37. Screening for cervical cancer: which common technique is the most cost-effective choice?
Wiwanitkit V
Asian Pac J Cancer Prev; 2009; 10(3):531-2. PubMed ID: 19640204
[TBL] [Abstract][Full Text] [Related]
38. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
[TBL] [Abstract][Full Text] [Related]
39. Does it matter? Discounting and its role in the cost-effectiveness of preventative interventions. The case of HPV vaccination.
Starkie Camejo H; Li X; Van Kriekinge G
Public Health; 2015 Jul; 129(7):989-92. PubMed ID: 25834927
[No Abstract] [Full Text] [Related]
40. HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness.
Coupé VM; van Ginkel J; de Melker HE; Snijders PJ; Meijer CJ; Berkhof J
Int J Cancer; 2009 Feb; 124(4):970-8. PubMed ID: 19035448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
